Immuneering Corporation (IMRX)
USD 1.62
(-6.36%)
USD 1.62
(-6.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -48.96 Million | -44.1 Million | -30.85 Million | -14.62 Million | -4.44 Million |
| Net Income | -53.47 Million | -50.51 Million | -33.53 Million | -17.03 Million | -7.7 Million |
| Depreciation & Amortization | 352.08 Thousand | 796.79 Thousand | 159.07 Thousand | 79.3 Thousand | 18.07 Thousand |
| Deferred income taxes | - | - | -307.48 Thousand | -349.96 Thousand | 739.03 Thousand |
| Stock-based compensation | 5.72 Million | 4.06 Million | 1.8 Million | 1.08 Million | 596.63 Thousand |
| Change in working capital | -974.64 Thousand | 1.71 Million | 900.41 Thousand | 1.25 Million | 437.12 Thousand |
| Other non-cash items | -601.58 Thousand | -166.21 Thousand | 130.24 Thousand | 349.96 Thousand | 1.47 Million |
| Investing Cash Flow | 7.29 Million | 41.83 Million | -75.61 Million | -53.41 Thousand | -20.52 Thousand |
| Investments in PPE | -342.74 Thousand | -742.48 Thousand | -60.78 Thousand | -53.41 Thousand | -20.52 Thousand |
| Acquisitions | -7.29 Million | -41.83 Million | 70.34 Thousand | - | - |
| Investment purchases | -44.66 Million | -50.1 Million | -75.62 Million | - | - |
| Sales/Maturities of investments | 52.3 Million | 92.67 Million | 75.61 Million | - | - |
| Other Investing Activities | 7.29 Million | 41.83 Million | -75.61 Million | - | - |
| Financing Cash Flow | 28.44 Million | 19 Thousand | 144.26 Million | 37.98 Million | 17.17 Million |
| Debt repayment | - | - | - | - | -3.82 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 28.2 Million | 19 Thousand | 120.31 Million | 37.98 Million | 17.22 Million |
| Other Financing Activities | 241.07 Thousand | 19 Thousand | 23.94 Million | 37.98 Million | -56.24 Thousand |
| Accounts receivables | 12.41 Thousand | 233.62 Thousand | 279.71 Thousand | -290.17 Thousand | 614.1 Thousand |
| Accounts payables | -1.1 Million | 1.76 Million | -130.39 Thousand | 1.18 Million | 270.49 Thousand |
| Inventory | - | - | - | - | 17.52 Thousand |
| Other working capital | 119.83 Thousand | -276.56 Thousand | 751.1 Thousand | 357.58 Thousand | -465 Thousand |
| Cash at beginning of period | 72.63 Million | 74.88 Million | 37.09 Million | 13.78 Million | 1.07 Million |
| Cash at end of period | 59.4 Million | 72.63 Million | 74.88 Million | 37.09 Million | 13.78 Million |
| Capital Expenditure | -342.74 Thousand | -742.48 Thousand | -60.78 Thousand | -53.41 Thousand | -20.52 Thousand |
| Effect of forex changes on cash | 48.96 Million | - | - | - | - |
| Net cash flow / Change in cash | -13.23 Million | -2.25 Million | 37.79 Million | 23.3 Million | 12.7 Million |
| Free Cash Flow | -49.31 Million | -44.84 Million | -30.91 Million | -14.67 Million | -4.46 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.07 Million | -14.3 Million | -15.08 Million | -53.47 Million | -12.59 Million | -12.18 Million |
| Depreciation & Amortization | 175.48 Thousand | 187.68 Thousand | 97.07 Thousand | 352.08 Thousand | 85.61 Thousand | -20.22 Thousand |
| Deferred income taxes | - | - | -620.18 Thousand | - | 620.18 Thousand | - |
| Stock-based compensation | 1.66 Million | 1.47 Million | 1.64 Million | 5.72 Million | 1.47 Million | 1.33 Million |
| Change in working capital | 724.48 Thousand | -2.68 Million | 1.88 Million | -974.64 Thousand | -794.68 Thousand | 27.06 Thousand |
| Other non-cash items | 1.61 Million | 1.57 Million | -313.03 Thousand | -601.58 Thousand | -822 Thousand | 99.55 Thousand |
| Investing Cash Flow | 4.96 Million | 21.39 Million | 3.13 Million | 7.29 Million | -23.97 Million | 9.16 Million |
| Investments in PPE | -32.77 Thousand | -37.47 Thousand | -170.91 Thousand | -342.74 Thousand | -57.14 Thousand | -86.68 Thousand |
| Acquisitions | - | - | -3.3 Million | -7.29 Million | 23.91 Million | - |
| Investment purchases | - | - | -15.74 Million | -44.66 Million | -28.91 Million | - |
| Sales/Maturities of investments | 5 Million | 21.43 Million | 19.05 Million | 52.3 Million | 5 Million | 9.25 Million |
| Other Investing Activities | 5 Million | 21.43 Million | 3.3 Million | 7.29 Million | -23.91 Million | 9.25 Million |
| Financing Cash Flow | - | 979.92 Thousand | 7835.00 | 28.44 Million | 21.44 Thousand | 28.17 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 979.92 Thousand | 7835.00 | 28.2 Million | 21.44 Thousand | 28.17 Million |
| Other Financing Activities | - | 979.92 Thousand | 7835.00 | 241.07 Thousand | 21.44 Thousand | 28.17 Million |
| Accounts receivables | - | - | -12.41 Thousand | 12.41 Thousand | - | 1046.00 |
| Accounts payables | 393.17 Thousand | 117.39 Thousand | 170.56 Thousand | -1.1 Million | -778.2 Thousand | -68.32 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 331.31 Thousand | -2.8 Million | 1.71 Million | 119.83 Thousand | -16.47 Thousand | 94.34 Thousand |
| Cash at beginning of period | 66.28 Million | 59.4 Million | 68.04 Million | 72.63 Million | 104.01 Million | 77.43 Million |
| Cash at end of period | 59.72 Million | 66.28 Million | 59.4 Million | 59.4 Million | 68.04 Million | 104.01 Million |
| Capital Expenditure | -32.77 Thousand | -37.47 Thousand | -170.91 Thousand | -342.74 Thousand | -57.14 Thousand | -86.68 Thousand |
| Effect of forex changes on cash | - | - | -36.79 Million | 48.96 Million | 36.79 Million | - |
| Net cash flow / Change in cash | -6.55 Million | 6.88 Million | -8.63 Million | -13.23 Million | -35.97 Million | 26.58 Million |
| Free Cash Flow | -11.55 Million | -15.52 Million | -11.94 Million | -49.31 Million | -12.08 Million | -10.83 Million |
NICK
SVM
600293
TRS
BKIRF
NHHHF